0.00Open0.00Pre Close0 Volume0 Open Interest30.00Strike Price0.00Turnover316.39%IV63.84%PremiumJul 5, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.0516Delta0.0207Gamma183.10Leverage Ratio-0.0744Theta0.0001Rho9.44Eff Leverage0.0017Vega
TG Therapeutics Stock Discussion
$AGBA Group(AGBA.US)$
$TG Therapeutics(TGTX.US)$
The company said fourth quarter loss narrowed to 9 cents a share from 39 cents a year earlier. That's smaller than the 11 cents expected by analysts polled by Capital IQ, according to MT Newswires.
Revenue for the three months ende...
No comment yet